2025–2031 Forecast: AI Clinical Matching Market Set for Explosive Growth
The AI-Based Clinical Trial Solutions for Patient Matching Market is undergoing a radical transformation. Valued at USD 228.6 million in 2022 , the market is projected to skyrocket to approximately USD 2,789.37 million by 2031 , registering a remarkable CAGR of 26.9% over the forecast period. This phenomenal rise is being fueled by the pressing demand for faster, more accurate, and cost-efficient clinical trial patient recruitment — a process traditionally plagued by delays, high costs, and trial failures. AI-powered platforms now enable rapid parsing of massive data sources — including electronic health records (EHRs) , genomic sequences , and real-world evidence (RWE) — to match eligible patients with trial protocols with unmatched speed and precision. This is ushering in a new era of precision medicine and trial optimization. Request Sample Report PDF (including TOC, Graphs & Tables): https://www.statsandresearch.com/request-sample/40463-global-ai-based-c...